Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The burden of type 2 diabetes: are we doing enough?

Zimmet P.

Diabetes Metab. 2003 Sep;29(4 Pt 2):6S9-18. Review.

PMID:
14502096
2.

[Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].

Szybiński Z.

Pol Arch Med Wewn. 2001 Sep;106(3):751-8. Polish.

PMID:
11928582
3.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
4.

The global burden of diabetes and its complications: an emerging pandemic.

van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B.

Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S3-8. doi: 10.1097/01.hjr.0000368191.86614.5a. Review.

PMID:
20489418
5.

The cost of treating type 2 diabetes (CODEIRE).

Nolan JJ, O'Halloran D, McKenna TJ, Firth R, Redmond S.

Ir Med J. 2006 Nov-Dec;99(10):307-10.

PMID:
17274175
6.

[Evaluation of the burden of diabetes in Poland].

Kissimova-Skarbek K, Pach D, Płaczkiewicz E, Szurkowska M, Szybiński Z.

Pol Arch Med Wewn. 2001 Sep;106(3):867-73. Polish.

PMID:
11928598
7.

Technology and the issue of cost/benefit in diabetes.

Giannini C, Mohn A, Chiarelli F.

Diabetes Metab Res Rev. 2009 Sep;25 Suppl 1:S34-44. doi: 10.1002/dmrr.986. Review.

PMID:
19662616
8.
9.

Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.

Guo JJ, Gibson JT, Gropper DM, Oswald SL, Barker KN.

Am J Manag Care. 1998 Oct;4(10):1433-46.

10.
12.

The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.

Davis WA, Knuiman MW, Hendrie D, Davis TM.

Intern Med J. 2006 Mar;36(3):155-61.

PMID:
16503950
13.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

14.

Epidemiology of diabetes.

Winer N, Sowers JR.

J Clin Pharmacol. 2004 Apr;44(4):397-405. Review.

PMID:
15051748
15.

Diabetes in Japan: a review of disease burden and approaches to treatment.

Neville SE, Boye KS, Montgomery WS, Iwamoto K, Okamura M, Hayes RP.

Diabetes Metab Res Rev. 2009 Nov;25(8):705-16. doi: 10.1002/dmrr.1012. Review.

PMID:
19795421
16.

[Is type-2 diabetes mellitus preventable?].

Jermendy G.

Orv Hetil. 2003 Sep 28;144(39):1909-17. Review. Hungarian.

PMID:
14598569
17.

[Diabetes the challenge for public health].

Chromińiska-Szosland DT.

Wiad Lek. 2002;55 Suppl 1(Pt 2):646-50. Polish.

PMID:
17474577
18.

[Evaluation and prevention of type II diabetes mellitus and cardiovascular diseases in obese children and adolescents: a public health intervention in a local health organisation in Rome (Italy)].

Doro Altan AM, Manca Bitti ML, Buonomo E, Scarcella P, Mancinelli S, Arcano S, Palombi L.

Ig Sanita Pubbl. 2008 May-Jun;64(3):345-60. Italian.

PMID:
18936798
19.

Obesity, insulin resistance and diabetes--a worldwide epidemic.

Seidell JC.

Br J Nutr. 2000 Mar;83 Suppl 1:S5-8. Review.

PMID:
10889785
20.

Global and societal implications of the diabetes epidemic.

Zimmet P, Alberti KG, Shaw J.

Nature. 2001 Dec 13;414(6865):782-7. Review.

PMID:
11742409
Items per page

Supplemental Content

Support Center